Reading the tape
NASDAQ: REGN
Regeneron Pharmaceuticals, Inc.
Healthcare · Biotechnology
Market Cap
$73.65B
52w High
$821.11
52w Low
$476.49
P/E
16.81
Volume
558.93K
Outstanding Shares
103.02M
Price vs Fundamentals
Why The Stock Is Moving
Fundamentals are supporting the moveModerate confidence
1Y Price: 30.53%Revenue (TTM): 5.92%FCF (TTM): 37.58%P/FCF: 20th pct
What changed
The stock rose 30.53% over the last year. Revenue grew 5.92% over the trailing twelve months. Operating margin moved from 27.2% to 24.32%. Free cash flow grew 37.58% over the trailing twelve months.
What the market seems to be pricing
The stock move broadly lines up with stronger business momentum, and the shares are still only around the 20th percentile of their historical P/FCF range.
What would invalidate this read
Operating margin is at 24.32%. Revenue grew 5.92% — this thesis depends on that trajectory holding. If revenue growth, margins, or free cash flow roll over while the stock keeps climbing, more of the move would be coming from multiple expansion than business progress.
Company profile
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.
CEOLeonard S. Schleifer
SectorHealthcare
IndustryBiotechnology
Employees15,158
IPO dateApr 2, 1991
Valuation
Forward P/E—
EV/EBITDA13.81
Enterprise value$80.33B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth19.04%
Gross margin84.55%▼0.90%vs FY2024
Operating margin24.32%▼11.22%vs FY2024
ROE14.41%▼4.12%vs FY2024
Analyst consensus
RatingBuy
Target price$865.68▲21.09%
34
Buy
14
Hold
0
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
Jul 30, 2026
Q3 FY26 · EPS est $10.85 · Revenue est $3.81B
View
Dividends
$3.64/shareQuarterlyEx-div May 20, 2026 · in 11dSafeREGN pays a dividend with a 0.51% declared yield, covered 11.0× by free cash flow.
Declared Yield
0.51%
Annual Div / Share
$3.64
CAGR
—
Payout Ratio
8.46%
Safe
Dividend Growth Rate
Dividend Safety
10/10Safe
Income Projection
Invest
$
Growth rate:
Reinvest dividends
Today
$5/yr
$0/mo
In 5 yrs
$5/yr
$0/mo
In 10 yrs
$5/yr
$0/mo
| Today | In 5 yrs | In 10 yrs |
|---|---|---|
$5/yr $0/mo | $5/yr $0/mo | $5/yr $0/mo |
Analysis
Dividend Strengths
Well-covered by free cash flow
The dividend is covered 11.0× by free cash flow, indicating the company generates sufficient cash to sustain and potentially grow the payout without straining its finances.
Risks to Watch
No strong risk signal stands out from the latest period pair.